Schedule 13D ownership disclosure
Kymera Therapeutics Inc
Security class unavailable · CUSIP: 501575104
Event date: 2020-08-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000875320-20-000034
- Form type
- SC 13D
- Filer
- Kymera Therapeutics, Inc.
- CIK
- CIK 1815442
- Filed
- Sep 03, 2020
- Reporting period
- Aug 25, 2020
- Description
- Schedule 13D beneficial ownership